All of the distinguished members of our advisory board have been advising and supporting
Biyee SciTech, Inc. since before its inception.
Charles Flather, MBA
Mr. Flather is the managing partner of Middlegreen Associates, an investment management
firm. Previously, he was with State Street Research and Management Company, another
Boston investment organization, where he was a managing partner and was in charge
of the corporate pension fund area, which from zero in 1966 had grown to $9 billion
of the firm’s $12 billion of assets under management. The partners sold State Street
Research to Metropolitan Life Insurance Company of New York in 1983, and Mr. Flather
left and formed Middlegreen Associates in 1986. He has accumulated several decades
of experience in successfully analyzing and investing in businesses of all sizes
across many industries and many geographies. He has served on a number of boards
of corporations and charities.
Mr. Flather holds an MBA from the Harvard Business School and a BA from Harvard
Robert T.V. Kung, PhD
Dr. Kung was the Chief Scientific Officer of ABIOMED Inc. For over two decades,
he led the research and development for a series of advanced medical devices. They
include the AbioCor, the world's first completely self-contained replacement
heart. He is a respected figure in the cardiac assist device field and has given
frequent lectures and presentations at international science and technology conferences
for circulatory support . He was principal investigator on numerous NIH grants and
contracts totaling more than $25M. He has published scores of scientific papers
and has been issued numerous patents, in the fields of artificial hearts, circulatory
support devices, surgical lasers, periodontal diagnostics, and others. His expertise
spans beyond R&D. He led the clinical trial for the AbioCor. He was responsible
for regulatory efforts at ABIOMED for almost a decade winning FDA approvals for
exceptionally sophisticated heart support systems. He frequently serves as a member
of an NIH Study Section reviewing SBIR grant applications.
Dr. Kung holds a PhD from Cornell University, BS from the City University of New
York, and did his postdoctoral research at Yale University.
Edward B. Marsh Jr., MD
Dr. Marsh is a Managing Director of MedTech Capital with 30 years of experience
in the hands-on practice of clinical medicine, principally in the nonsurgical areas
of pediatrics, family medicine, emergency and military medicine, and occupational
health and safety. The settings of these practices varied widely, from a 2-person
private practice to a 600-clinician multispecialty HMO, to a deployable Army Reserve
unit. In addition to a clinical practice, Ed chaired for 20 years an Institutional
Review Board for Human Subjects Research overseeing compliance with Federal Guidelines.
Within the HMO, he conceived, developed, and managed a $1.5M Occupational Medicine
“start-up” subunit, and achieved profitable status within the first year. He was
elected several times to the Board of Trustees of the HMO, and was part of a select
committee designated to investigate and select an electronic medical record system
for the organization. He held a faculty appointment to Harvard Medical School throughout
his clinical career, and resigned from the Army Reserves at the rank of Colonel.
Dr. Marsh has an AB from Princeton University, an MD from Johns Hopkins University
and completed approximately half the requirements for an MPH from Medical College